You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Bulk Pharmaceutical API Sources for BACTOCILL IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for BACTOCILL IN PLASTIC CONTAINER

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free O1002_SIAL ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-006-395-548 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS016008877 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: BACTOCILL IN PLASTIC CONTAINER

Last updated: July 31, 2025


Introduction

The procurement of high-quality Active Pharmaceutical Ingredients (APIs) is pivotal for pharmaceutical manufacturers producing Bactocill, a well-known antibiotic composed of penicillin-based compounds. In particular, the sourcing of API in plastic container packaging demands adherence to strict regulatory standards, ensuring stability, potency, and safety throughout manufacturing and storage.


Overview of Bactocill and API Requirements

Bactocill, historically marketed as a penicillin antibiotic, combats bacterial infections by inhibiting cell wall synthesis. The active ingredient chiefly involves Penicillin G (benzylpenicillin) or its derivatives, necessitating APIs that meet stringent pharmacological, microbiological, and physicochemical criteria.

API sourcing for Bactocill involves considerations of:

  • Purity standards (typically >99%)
  • Particle size consistency
  • Stability in packaging materials
  • Compliance with regulatory agencies such as the FDA, EMA, and WHO
  • Supply chain reliability for large-scale manufacturing

Key Sources of API for Bactocill in Plastic Containers

1. Major Global API Manufacturers

a. GlaxoSmithKline (GSK)

As the original developer of Bactocill, GSK remains a strategic supplier of Penicillin G API. Their manufacturing facilities adhere to cGMP standards and possess extensive experience in antibiotic API production. GSK's APIs are supplied in various packaging formats, including plastic containers designed for stability and ease of handling.

b. Novartis

Novartis is a significant supplier of penicillin APIs globally, offering high-quality Penicillin G with consistent batch quality. Their APIs are appreciated for low endotoxin levels and robust stability profiles conducive to packaging in plastic containers.

c. Pfizer

Pfizer manufactures Penicillin G APIs suitable for broad pharmaceutical applications, with well-established supply chains. Their APIs comply with international pharmacopeial standards, enabling formulators to opt for plastic container packaging without compromising API integrity.

d. Teva Pharmaceuticals

A leading generic manufacturer, Teva offers affordable, high-quality penicillin APIs. Their manufacturing processes include rigorous purification steps, ensuring API suitability for long-term storage in plastic bottles.

e. Sandoz (Novartis offshoot)

Specializing in biosimilars and generics, Sandoz supplies Penicillin G API with a focus on stability, purity, and cost-effectiveness, aligned with global regulatory criteria.


2. Regional API Producers

a. Dr. Reddy’s Laboratories (India)

As a major regional API producer, Dr. Reddy’s supplies Penicillin G API to Asia, Africa, and parts of Latin America. Their products meet WHO prequalification standards, with packaging options compatible with plastic containers.

b. Hetero Drugs (India)

Hetero specializes in antibiotic APIs and offers Penicillin G API with high purity, tailored for global export. Their manufacturing facilities hold GMP certifications, and APIs are compatible with plastic packaging for stability.

c. Zhejiang Hisun Pharmaceutical (China)

A rapidly growing API manufacturer providing Penicillin G API compliant with CE and WHO standards, suitable for bulk pharmaceutical in plastic containers.


Regulatory Considerations for API Sourcing

Choosing an API supplier involves validating compliance with Good Manufacturing Practices (GMP), ensuring batch-to-batch consistency, and verifying regulatory approvals. For Bactocill, APIs must conform to standards such as USP, EP, or Ph. Eur. specifications. Manufacturers must also consider stability data when APIs are destined for plastic container packaging.

Furthermore, the packaging materials (e.g., polyethylene, polypropylene) must be chemically inert, non-reactive, and capable of maintaining API stability over the product’s shelf life—especially critical for sensitive antibiotics like penicillin.


Quality and Stability in Plastic Container Packaging

APIs in plastic containers require meticulous handling to maintain chemical stability, prevent contamination, and avoid degradation. Suppliers often provide stability data demonstrating API compatibility with specific plastics under various conditions (temperature, humidity). High-quality APIs feature low moisture content and endotoxin levels to facilitate safe storage in plastic formats.


Supply Chain and Risk Mitigation

Global disruptions, regulatory changes, and quality concerns underscore the importance of diversified sourcing. Establishing multiple API suppliers mitigates risk, ensures competitive pricing, and secures consistent supply. Advanced API manufacturers with proven track records and established quality control systems are preferred partners.


Emerging Trends and Alternatives

  • Bio-synthetically produced APIs offer improved purity and stability.
  • Local manufacturing initiatives in emerging markets aim to reduce dependency on long international supply chains.
  • Innovations in packaging materials, such as multi-layered plastics with better barrier properties, extend API stability.

Conclusion

Securing high-quality Penicillin G API for Bactocill in plastic containers requires careful selection of suppliers adhering to international standards. Major global pharmaceutical companies—GSK, Novartis, Pfizer, and Teva—are primary sources that provide APIs with proven stability profiles compatible with plastic packaging. Regional producers such as Dr. Reddy’s and Hetero further expand options for diverse markets.

Procuring APIs from suppliers committed to GMP compliance, rigorous quality control, and stability data ensures product integrity, regulatory compliance, and supply chain resilience.


Key Takeaways

  • Top-tier global pharmaceutical companies remain primary sources for Penicillin G API, offering high purity and regulatory compliance.
  • Regional manufacturers in India and China provide cost-effective, quality-assured APIs suitable for plastic container packaging.
  • API in plastic containers must adhere to stability and inertness standards; supplier transparency on stability data is critical.
  • Diversifying API supply reduces risk and ensures continuous production.
  • Advances in packaging and API manufacturing promote enhanced stability, extending shelf life and maintaining efficacy.

FAQs

Q1: What qualities should I look for in an API supplier for Bactocill?
A1: Ensure the supplier complies with GMP, provides APIs meeting pharmacopeial standards (USP, EP, Ph. Eur.), has proven stability data compatible with plastic packaging, and maintains rigorous quality control processes.

Q2: Why is plastic container packaging commonly used for API storage?
A2: Plastic containers are cost-effective, lightweight, chemically inert, and provide flexibility in handling and storage. They are suitable for APIs with stability profiles that tolerate plastic materials if properly validated.

Q3: Are there regulatory concerns with APIs in plastic containers?
A3: Yes. Regulatory agencies require validation that APIs remain stable and uncontaminated within plastic packaging over their shelf life. Suppliers must provide stability data, and manufacturers should conduct container compatibility testing.

Q4: How does regional manufacturing impact API quality?
A4: While regional manufacturers can offer cost advantages, it is vital to verify their compliance with international quality standards, GMP, and regulatory approvals to ensure API quality and stability.

Q5: What are emerging trends in API sourcing for antibiotics like Bactocill?
A5: Trends include bio-synthetic API production for higher purity, diversification of supply chains, investments in advanced container materials, and local manufacturing initiatives to enhance supply security.


Sources:

  1. [1] World Health Organization. WHO Prequalification Programme. API manufacturing standards.
  2. [2] United States Pharmacopeia. USP Monographs on Penicillin G.
  3. [3] European Pharmacopoeia. Monographs on Penicillin API.
  4. [4] GSK Annual Reports & Product Datasheets.
  5. [5] Industry reports on global API manufacturing and supply chain dynamics.

Disclaimer: This article aims to provide a comprehensive overview of API sources for Bactocill in plastic containers based on current industry standards and is not an endorsement of any specific supplier. Always conduct thorough due diligence and regulatory validation before procurement.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.